Almirall's constipation drug Constella gets clear passage through CHMP
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's Committee for Medicinal Products for Human Use has bestowed a positive opinion upon Almirall/ Ironwood Pharmaceuticals' drug for irritable bowel syndrome with constipation (IBS-C), Constella (linaclotide).